Search Results - Montanya, Eduard, Prof

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

    Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6) by Buse, John B, Prof, Rosenstock, Julio, MD, Sesti, Giorgio, Prof, Schmidt, Wolfgang E, Prof, Montanya, Eduard, Prof, Brett, Jason H, MD, Zychma, Marcin, MD, Blonde, Lawrence, MD

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial

    Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial by Pratley, Richard E, Dr, Nauck, Michael, Prof, Bailey, Timothy, MD, Montanya, Eduard, Prof, Cuddihy, Robert, MD, Filetti, Sebastiano, Prof, Thomsen, Anne Bloch, MD, Søndergaard, Rie Elvang, MSc, Davies, Melanie, Prof

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: